🔴 GeneDx is trading 4.19% down today as yields and inflation concerns pressure biotech stocks

GeneDx is trading 4.19% lower at $87.00 as broad risk-off pressure weighs on growth-oriented healthcare stocks across the market.

• No verified company-specific announcement, earnings update, regulatory action, or analyst downgrade was identified for September 23, 2026.
• The Nasdaq fell 1.07%, the S&P 500 declined 0.69%, and biotech ETF XBI dropped 2.04% as rising Treasury yields and inflation concerns pressured growth-oriented healthcare stocks.